在小鼠的α1b-上腺素受体缺陷的心血管影响
Carmine Vecchione1, Luigi Fratta, Damiano Rizzoni
1I.R.C.C.S. Neuromed, Pozzilli, IS, Italy.
Circulation
|April 10, 2002
概括
阿尔法1b-上腺素受体 (alpha1b-AR) 对上腺素诱导的血压升高和心血管改造至关重要. 缺少α1b-AR可以防止这些上腺作用.
科学领域:
- 心血管生理学心血管生理学
- 上腺体受体信号传递
- 高血压研究 高血压研究
背景情况:
- 阿尔法1-上腺素受体 (alpha1-ARs) 对于维持心血管平衡至关重要.
- 阿尔法1-AR亚型的特定体内作用在很大程度上仍未定义.
- 这项研究的重点是阐明alpha1b-AR亚型的心血管功能.
研究的目的:
- 为了研究由α1b-上腺体受体介导的特定心血管作用.
- 确定alpha1b-AR在血压调节和心血管改造中的作用.
主要方法:
- 使用了缺乏alpha1-AR和野生类型 (WT) 控制的淘汰赛 (KO) 鼠标.
- 慢性地通过奥斯摩斯给出诺拉上腺素,血管新生素II和上腺素.
- 评估血压概况和心血管改造,包括心脏缩和血管改造.
主要成果:
- 上腺素导致血压升高,并仅在WT小鼠中诱导心脏和血管重塑.
- 在WT和KO小鼠中, ангиотензинII诱导的高血压是相似的.
- 由于大动脉收缩引起的心脏缩在WT和KO小鼠之间是可比的,这表明alpha1b-AR在上腺介导重塑中的特定作用.
结论:
- 缺少α1b-AR可以保护人们免受北上腺素诱导的慢性高血压.
- 缺少α1b-AR可以防止上腺激素介导的心血管重塑,无论血压变化如何.
- 阿尔法1b-AR是北上腺素对心血管有害影响的关键调解者.
相关概念视频
Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...


